Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Swiss update pandemic hygiene mask standards:

This article was originally published in Clinica

Executive Summary

The proliferation of hygiene masks of varying quality on the market in Switzerland has prompted national regulatory authority Swissmedic to issue a standard practice reminder. Swiss federal health office (BAG) policy is to recommend that the public use hygiene masks in cases of pandemics, Swissmedic told a 30-strong gathering of industry representatives in Bern. Type II and IIR hygiene masks (all of which are subject to CE-marking under the EU's MDD) are its preferred models. They meet the criterion of 98% bacterial filter efficiency (BFE). Manufacturers must conform to EN 14683, said the authority, adding that products already in circulation that do not meet these standards will not be withdrawn, but should be used indoors only. It is difficult to estimate the number of brands available, as Switzerland has "free market" for such products, said Swissmedic.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049191

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel